Physician profile
Darren Franczyk
NPI 1275532939
$868.16
in general payments reported to CMS, 2019-2025
14 companies · $279 in 2025
The $279 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $64.15 · 2021: $45.10 · 2022: $14.43 · 2023: $79.19 · 2024: $139 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $168.47 | 2019-2024 | |
| Glaxosmithkline, LLC. | $151.43 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $124.21 | 2020-2025 | Vaxelis, Vaxneuvance, Rotateq |
| Sanofi Pasteur INC. | $117.75 | 2021-2025 | |
| Kaleo, INC. | $52.88 | 2019-2024 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $50.92 | 2025 | Jornay Pm |
| Pfizer INC. | $48.43 | 2023-2024 | |
| Tris Pharma INC | $39.13 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $26.98 | 2024 | |
| Supernus Pharmaceuticals, INC. | $19.95 | 2021 | |
| Sobi, INC | $19.62 | 2019 | |
| Alk-Abello, INC | $19.38 | 2025 | Neffy |
| Shire North American Group INC | $16.09 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.92 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Franczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.